DNLI
Price
$14.01
Change
+$0.39 (+2.86%)
Updated
Jun 24, 12:55 PM (EDT)
Capitalization
1.98B
37 days until earnings call
PRAX
Price
$42.44
Change
+$0.81 (+1.95%)
Updated
Jun 24, 12:53 PM (EDT)
Capitalization
862.42M
56 days until earnings call
Interact to see
Advertisement

DNLI vs PRAX

Header iconDNLI vs PRAX Comparison
Open Charts DNLI vs PRAXBanner chart's image
Denali Therapeutics
Price$14.01
Change+$0.39 (+2.86%)
Volume$200
Capitalization1.98B
Praxis Precision Medicines
Price$42.44
Change+$0.81 (+1.95%)
Volume$100
Capitalization862.42M
DNLI vs PRAX Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. PRAX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and PRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (DNLI: $13.62 vs. PRAX: $41.63)
Brand notoriety: DNLI and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 104% vs. PRAX: 68%
Market capitalization -- DNLI: $1.98B vs. PRAX: $862.42M
DNLI [@Biotechnology] is valued at $1.98B. PRAX’s [@Biotechnology] market capitalization is $862.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRAX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 2 TA indicator(s) are bullish while PRAX’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 2 bullish, 6 bearish.
  • PRAX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -6.84% price change this week, while PRAX (@Biotechnology) price change was -4.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.99%. For the same industry, the average monthly price growth was +34.45%, and the average quarterly price growth was +16.31%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

PRAX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+3.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($1.98B) has a higher market cap than PRAX($862M). DNLI YTD gains are higher at: -33.170 vs. PRAX (-45.907). PRAX has higher annual earnings (EBITDA): -232.71M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. PRAX (328M). PRAX has less debt than DNLI: PRAX (1.07M) vs DNLI (48.6M). PRAX has higher revenues than DNLI: PRAX (8.12M) vs DNLI (0).
DNLIPRAXDNLI / PRAX
Capitalization1.98B862M230%
EBITDA-505.16M-232.71M217%
Gain YTD-33.170-45.90772%
P/E RatioN/AN/A-
Revenue08.12M-
Total Cash818M328M249%
Total Debt48.6M1.07M4,559%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIPRAX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EPLCX22.130.19
+0.87%
NYLI Epoch U.S. Equity Yield Class I
DNSVX14.01N/A
N/A
Dunham Small Cap Value N
CSSZX20.43N/A
N/A
Columbia Select Small Cap Value Inst
HIACX52.74N/A
N/A
Hartford Capital Appreciation HLS IA
RSLDX70.42N/A
N/A
American Funds SMALLCAP World R5E

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with NRIX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-1.94%
NRIX - DNLI
56%
Loosely correlated
+4.26%
BEAM - DNLI
56%
Loosely correlated
-0.30%
OCUL - DNLI
55%
Loosely correlated
+2.83%
RGNX - DNLI
54%
Loosely correlated
-6.76%
ARWR - DNLI
54%
Loosely correlated
+1.24%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-1.68%
CDXS - PRAX
49%
Loosely correlated
+3.06%
MNMD - PRAX
45%
Loosely correlated
-5.74%
DNLI - PRAX
45%
Loosely correlated
-1.94%
ABCL - PRAX
41%
Loosely correlated
-2.35%
XENE - PRAX
40%
Loosely correlated
-1.75%
More